| 
                                    
PF-670462 dihydrochloride
                            - 英文名称:PF-670462 dihydrochloride
 
- 品牌:WYTSCI
 
- 产地:进口
 
- 型号:1MG
 
- 货号:WT-AY-B11368
 
- cas:950912-80-8
 
- 价格: ¥1/mg
 - 发布日期: 2025-04-10
 - 更新日期: 2025-11-04
 
产品详请
            | 产地 | 进口 | 
| 品牌 | WYTSCI | 
| 货号 | WT-AY-B11368 | 
| 用途 | 科研检测 | 
| 英文名称 | PF-670462 dihydrochloride | 
| 包装规格 | 1MG | 
| CAS编号 | 950912-80-8 | 
| 别名 | PF-670462 dihydrochloride | 
| 纯度 | 98+% | 
| 分子式 | |
| 是否进口 | 是 | 
                纯度:>98% by HPLC,;NMR (Conforms) 
分子式:C19H22Cl2FN5
分子量:337.4
溶剂:DMSO (25 mg/ml)
性状:Off-white solid
存储:-20°C
Activity (short version):Casein kinase 1δ/ε inhibitor
Function / Pharmacology:Potent inhibitor of casein kinase 1ε/δ (CK1ε, IC50 = 7.7 nM; CK1δ, IC50 = 14 nM).1 It is a circadian clock modifier that caused robust phase delays in rats1 and Cynomolgus monkeys2. PF-670462 caused nuclear retention of the clock protein PER resulting in period lengthening in a phase-specific manner that was dependent on CK1δ inhibition and not CK1ε.3 It improved cognitive performance and reduced amyloid load in various mouse models of Alzheimer’s disease.4-6 PF-670462 slowed the progression of and increased survival of chronic lymphocytic leukemia in mice alone and in combination with Ibrutinib.7
            
        分子式:C19H22Cl2FN5
分子量:337.4
溶剂:DMSO (25 mg/ml)
性状:Off-white solid
存储:-20°C
Activity (short version):Casein kinase 1δ/ε inhibitor
Function / Pharmacology:Potent inhibitor of casein kinase 1ε/δ (CK1ε, IC50 = 7.7 nM; CK1δ, IC50 = 14 nM).1 It is a circadian clock modifier that caused robust phase delays in rats1 and Cynomolgus monkeys2. PF-670462 caused nuclear retention of the clock protein PER resulting in period lengthening in a phase-specific manner that was dependent on CK1δ inhibition and not CK1ε.3 It improved cognitive performance and reduced amyloid load in various mouse models of Alzheimer’s disease.4-6 PF-670462 slowed the progression of and increased survival of chronic lymphocytic leukemia in mice alone and in combination with Ibrutinib.7

    
           
           
           
                                
             
             

